134 related articles for article (PubMed ID: 35158098)
1. Targeting HNRNPM Inhibits Cancer Stemness and Enhances Antitumor Immunity in Wnt-activated Hepatocellular Carcinoma.
Zhu GQ; Wang Y; Wang B; Liu WR; Dong SS; Chen EB; Cai JL; Wan JL; Du JX; Song LN; Chen SP; Yu L; Zhou ZJ; Wang Z; Zhou J; Shi YH; Fan J; Dai Z
Cell Mol Gastroenterol Hepatol; 2022; 13(5):1413-1447. PubMed ID: 35158098
[TBL] [Abstract][Full Text] [Related]
2. microR-505/heterogeneous nuclear ribonucleoprotein M inhibits hepatocellular carcinoma cell proliferation and induces cell apoptosis through the Wnt/β-catenin signaling pathway.
Chi X; Jiang Y; Chen Y; Lv L; Chen J; Yang F; Zhang X; Pan F; Cai Q
Biomark Med; 2020 Jul; 14(11):981-996. PubMed ID: 32940078
[No Abstract] [Full Text] [Related]
3. Heterogeneous nuclear ribonucleoprotein M promotes the progression of breast cancer by regulating the axin/β-catenin signaling pathway.
Yang WH; Ding MJ; Cui GZ; Yang M; Dai DL
Biomed Pharmacother; 2018 Sep; 105():848-855. PubMed ID: 30021377
[TBL] [Abstract][Full Text] [Related]
4. HNRNPM controls circRNA biogenesis and splicing fidelity to sustain cancer cell fitness.
Ho JS; Di Tullio F; Schwarz M; Low D; Incarnato D; Gay F; Tabaglio T; Zhang J; Wollmann H; Chen L; An O; Chan THM; Hall Hickman A; Zheng S; Roudko V; Chen S; Karz A; Ahmed M; He HH; Greenbaum BD; Oliviero S; Serresi M; Gargiulo G; Mann KM; Hernando E; Mulholland D; Marazzi I; Wee DKB; Guccione E
Elife; 2021 Jun; 10():. PubMed ID: 34075878
[TBL] [Abstract][Full Text] [Related]
5. Targeting Jak/Stat pathway as a therapeutic strategy against SP/CD44+ tumorigenic cells in Akt/β-catenin-driven hepatocellular carcinoma.
Toh TB; Lim JJ; Hooi L; Rashid MBMA; Chow EK
J Hepatol; 2020 Jan; 72(1):104-118. PubMed ID: 31541681
[TBL] [Abstract][Full Text] [Related]
6. Cellular retinol binding protein-1 inhibits cancer stemness via upregulating WIF1 to suppress Wnt/β-catenin pathway in hepatocellular carcinoma.
Liu X; Shan W; Li T; Gao X; Kong F; You H; Kong D; Qiao S; Tang R
BMC Cancer; 2021 Nov; 21(1):1224. PubMed ID: 34775955
[TBL] [Abstract][Full Text] [Related]
7. Cripto-1 contributes to stemness in hepatocellular carcinoma by stabilizing Dishevelled-3 and activating Wnt/β-catenin pathway.
Lo RC; Leung CO; Chan KK; Ho DW; Wong CM; Lee TK; Ng IO
Cell Death Differ; 2018 Aug; 25(8):1426-1441. PubMed ID: 29445127
[TBL] [Abstract][Full Text] [Related]
8. miR-122 enhances sensitivity of hepatocellular carcinoma to oxaliplatin via inhibiting MDR1 by targeting Wnt/β-catenin pathway.
Cao F; Yin LX
Exp Mol Pathol; 2019 Feb; 106():34-43. PubMed ID: 30539797
[TBL] [Abstract][Full Text] [Related]
9. Transcription factor AP-4 promotes tumorigenic capability and activates the Wnt/β-catenin pathway in hepatocellular carcinoma.
Song J; Xie C; Jiang L; Wu G; Zhu J; Zhang S; Tang M; Song L; Li J
Theranostics; 2018; 8(13):3571-3583. PubMed ID: 30026867
[TBL] [Abstract][Full Text] [Related]
10. Hyperactivation of β-catenin signal in hepatocellular carcinoma recruits myeloid-derived suppressor cells through PF4-CXCR3 axis.
Wang K; Wu J; Yang Z; Zheng B; Shen S; Wang RR; Zhang Y; Wang HY; Chen L; Qiu X
Cancer Lett; 2024 Apr; 586():216690. PubMed ID: 38307410
[TBL] [Abstract][Full Text] [Related]
11. HBX-induced miR-5188 impairs FOXO1 to stimulate β-catenin nuclear translocation and promotes tumor stemness in hepatocellular carcinoma.
Lin X; Zuo S; Luo R; Li Y; Yu G; Zou Y; Zhou Y; Liu Z; Liu Y; Hu Y; Xie Y; Fang W; Liu Z
Theranostics; 2019; 9(25):7583-7598. PubMed ID: 31695788
[TBL] [Abstract][Full Text] [Related]
12. Downregulation of Cancer Stemness by Novel Diterpenoid Ovatodiolide Inhibits Hepatic Cancer Stem Cell-Like Traits by Repressing Wnt/[Formula: see text]-Catenin Signaling.
Liu M; Bamodu OA; Kuo KT; Lee WH; Lin YK; Wu ATH; M H; Tzeng YM; Yeh CT; Tsai JT
Am J Chin Med; 2018; 46(4):891-910. PubMed ID: 29792038
[TBL] [Abstract][Full Text] [Related]
13. The microtubule-associated protein PRC1 promotes early recurrence of hepatocellular carcinoma in association with the Wnt/β-catenin signalling pathway.
Chen J; Rajasekaran M; Xia H; Zhang X; Kong SN; Sekar K; Seshachalam VP; Deivasigamani A; Goh BK; Ooi LL; Hong W; Hui KM
Gut; 2016 Sep; 65(9):1522-34. PubMed ID: 26941395
[TBL] [Abstract][Full Text] [Related]
14. hnRNPM guides an alternative splicing program in response to inhibition of the PI3K/AKT/mTOR pathway in Ewing sarcoma cells.
Passacantilli I; Frisone P; De Paola E; Fidaleo M; Paronetto MP
Nucleic Acids Res; 2017 Dec; 45(21):12270-12284. PubMed ID: 29036465
[TBL] [Abstract][Full Text] [Related]
15. Cell type-restricted activity of hnRNPM promotes breast cancer metastasis via regulating alternative splicing.
Xu Y; Gao XD; Lee JH; Huang H; Tan H; Ahn J; Reinke LM; Peter ME; Feng Y; Gius D; Siziopikou KP; Peng J; Xiao X; Cheng C
Genes Dev; 2014 Jun; 28(11):1191-203. PubMed ID: 24840202
[TBL] [Abstract][Full Text] [Related]
16. Disruption of SIRT7 Increases the Efficacy of Checkpoint Inhibitor via MEF2D Regulation of Programmed Cell Death 1 Ligand 1 in Hepatocellular Carcinoma Cells.
Xiang J; Zhang N; Sun H; Su L; Zhang C; Xu H; Feng J; Wang M; Chen J; Liu L; Shan J; Shen J; Yang Z; Wang G; Zhou H; Prieto J; Ávila MA; Liu C; Qian C
Gastroenterology; 2020 Feb; 158(3):664-678.e24. PubMed ID: 31678303
[TBL] [Abstract][Full Text] [Related]
17. hnRNPM, a potential mediator of YY1 in promoting the epithelial-mesenchymal transition of prostate cancer cells.
Yang T; An Z; Zhang C; Wang Z; Wang X; Liu Y; Du E; Liu R; Zhang Z; Xu Y
Prostate; 2019 Aug; 79(11):1199-1210. PubMed ID: 31251827
[TBL] [Abstract][Full Text] [Related]
18. Targeting glutaminase 1 attenuates stemness properties in hepatocellular carcinoma by increasing reactive oxygen species and suppressing Wnt/beta-catenin pathway.
Li B; Cao Y; Meng G; Qian L; Xu T; Yan C; Luo O; Wang S; Wei J; Ding Y; Yu D
EBioMedicine; 2019 Jan; 39():239-254. PubMed ID: 30555042
[TBL] [Abstract][Full Text] [Related]
19. Intrinsic activation of β-catenin signaling by CRISPR/Cas9-mediated exon skipping contributes to immune evasion in hepatocellular carcinoma.
Akasu M; Shimada S; Kabashima A; Akiyama Y; Shimokawa M; Akahoshi K; Kudo A; Yamaoka S; Tanabe M; Tanaka S
Sci Rep; 2021 Aug; 11(1):16732. PubMed ID: 34429454
[TBL] [Abstract][Full Text] [Related]
20. Repression of WT1-Mediated LEF1 Transcription by Mangiferin Governs β-Catenin-Independent Wnt Signalling Inactivation in Hepatocellular Carcinoma.
Tan HY; Wang N; Li S; Hong M; Guo W; Man K; Cheng CS; Chen Z; Feng Y
Cell Physiol Biochem; 2018; 47(5):1819-1834. PubMed ID: 29953980
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]